Health Insurer Plans To Optimize Drug Treatment Using Data Analytics

New Jersey’s largest health insurer has partnered with a biopharma vendor to optimize drug treatment using medical and pharmacy claims data.  Horizon Healthcare Services will work with vendor Aetion to support case management strategies and develop value-based agreements with pharmas targeting specific patient populations. Aetion is in the business of providing payers and biopharma companies […]
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Ambulatory Analytics/Big Data Clinical Healthcare IT Hospital - Health System Aetion AstraZeneca Boehringer Ingelheim Eli Lilly and Company Geisinger Horizon Healthcare Services Type 2 Diabetes UPMC Health Plan Value-Based Contra Source Type: blogs

Related Links:

Publication date: Available online 17 July 2019Source: Journal of Molecular BiologyAuthor(s): Peter Spégel, Hindrik MulderAbstractThe islets of Langerhans harbor multiple endocrine cell-types that continuously respond to circulating nutrient levels in order to adjust their secretion of catabolic and anabolic hormones. Stimulus-secretion coupling in these cells is largely of metabolic nature, i.e. metabolism of nutrient fuels yields signals that trigger and amplify secretion of hormones. Hence, metabolism in this micro-organ is in a major way in control of whole-body metabolism. Therefore, insights into islet metabol...
Source: Journal of Molecular Biology - Category: Molecular Biology Source Type: research
Authors: Kalra S, Sahay R Abstract This brief communication describes evidence which proves the beneficial effects of fenofibrate on the retinal vasculature in type 2 diabetes, acting via both lipid lowering and non-lipid lowering mechanisms. It discusses data from FIELD and other trials to support the use of fenofibrate as a secondary preventive therapy for diabetic retinopathy. These data contrast with the lack of retinal benefit shown in major cardiovascular outcome trials of other blood pressure lowering and glucose lowering agents such as empagliflozin, liraglutide, perindopril + indapamide, and ramipril. ...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Authors: Patil MB, Ragav ED Abstract Introduction: Type-2 Diabetes is a heterogeneous group of disorders characterized by variable degrees of insulin resistance, impaired insulin secretion, and increased glucose production. Obese diabetic patients have 13.5% more chances of developing diabetic complications compared to non - obese diabetic patients. Vitamin D has found to be deficient in diabetic patient and it's role in insulin regulation. Obese females are more prone to develop diabetic complications and hypovitaminosis-D. Materials and Method: Total of 156 female diabetic patients aged 30 to 60 years who are...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
This study aimed at estimating the prevalence of GDM among antenatal women attending a rural secondary care hospital in southern India and attempts to study associations between anthropometry, parental history, physical activity of pregnant women and GDM. Methods: A hospital based cross sectional study was done among 630 pregnant women who were screened with oral glucose tolerance test between 24 and 28 weeks of gestation based on IADPSG criteria. Risk factors for developing GDM were assessed by conducting home visits to 75 women diagnosed to have GDM and 150 randomly selected women without GDM. Results: Hospital b...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Authors: Bhagat AK, Bhardwaj H, Bhardwaj BL, Goyal S, Jaura S, Jain P Abstract Introduction: Cataract represents one of the most frequent eye complications in type 1 DM and type 2 DM patients; contrarily, acute cataract in young diabetic patients occurs very rarely. Only few cases with acute bilateral cataract - all relatively shortly after the diagnosis of type 1 DM have been reported. It can affect visual acuity from slight visual impairment to complete blindness. Although usually associated with chronic hyperglycaemia, it may also occur on rapid restoration of euglycaemia.1 Early detection of diabetes and adequa...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
 Targeting Glycemic Level in Gestational Diabetes Mellitus to that of Normal Pregnancy would result in a better Maternal-Fetal Outcome. J Assoc Physicians India. 2019 Apr;67(4):66-70 Authors: Seshiah V, Kapur A, Balaji V, Shah SN, Das AK, Diwakar H, Banerjee S, Anjalakshi C Abstract Abstract: Women with a history of Gestational Diabetes Mellitus (GDM) are at increased risk of future diabetes and related Non-Communicable Diseases (NCD) as are their offspring. "Transgenerational transmission occurs". Independent of genetic risk, offspring of hyperglycaemic pregnancies are at increased risk...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
 Study of Impact of Glycemic Status (HbA1c) on Platelet Activity measured by Mean Platelet Volume &Vascular Complications in Diabetics. J Assoc Physicians India. 2019 Apr;67(4):26-29 Authors: Saluja M, Swami YK, Meena SR Abstract Introduction: Diabetes mellitus is a global pandemic. The increased platelet activity may play a role in the development of vascular complications of this metabolic disorder. The mean platelet volume (MPV) is an indicator of the average size and activity of platelets. Larger platelets are younger and exhibit more activity. Aims and Objectives: To determine the MPV...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study. Endocr J. 2019 Jul 12;: Authors: Shimoda S, Sakamoto W, Hokamura A, Matsuo Y, Sekigami T, Ichimori S, Iwashita S, Ishii N, Otsu K, Yoshimura R, Nishiyama T, Sakaguchi M, Nishida K, Araki E Abstract To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-gener...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
TYPE 2 diabetes is when the pancreas does not make enough insulin or when the body can no longer use the insulin it makes. A popular lunch item could make symptoms worse and increase a person ’s risk. What is it?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
We describe the implementation, clinical outcomes and participant perspectives for e-Healthystrides©. Setting: Three independent ambulatory clinics and an historic African American (AA) church. Participants: Adults with diagnosed diabetes mellitus type 2. Intervention: e-Healthystrides© health coach facilitated intervention. Primary outcome: Acquisition of three new self-management behaviors. Secondary outcomes: Blood pressure, blood glucose, A1c, attrition rate and participant perspectives of e-Healthystrides©. Methods: A convergent parallel mixed method design was used in both pilot...
Source: Ethnicity and Disease - Category: International Medicine & Public Health Tags: Ethn Dis Source Type: research
More News: AstraZeneca | Diabetes | Diabetes Type 2 | Endocrinology | HIPAA | Hospitals | Information Technology | Insurers